prescribing/drugs and therapeutics lectures Flashcards
ACE inhibitors
ACE inhibitors (ramipril, lisinopril, enalapril)
Block ACE to prevent the conversion of AT1 to AT2. AT2 causes vasocon and aldosterone secretion. ACEI reduces afterload, preload, pref dilates efferent glomerular arteriole to reduce interglomerular pressure and slow CKD progression. Indications: HTN, CHF, Ischaemic HD, Diabetic nephropathy, CKD with proteinuria.
Prescription: Ramipril 2.5mg OD PO most common, 1.25 mg in HF or nephropathy. Titrate up to max 10mg per day.
Side effects: bradykinin cough. Hyperkalaemia. Renal failure in renal artery stenosis pts or when with NSAIDS.
Contraindictations:. PARK: Pregnancy/breastfeeding Aki Renal artery stenosis K increase (hyperkalemia)
Adrenaline
Adrenaline*
Alpha 1 and 2, beta1 and 2 agonist. Alpha1 – skin, mucosal, abdo viscera vasoconstriction. Beta1 – increases myocardial rate, force and excitability. Beta2 – vasodilate muscle and heart vessels, also bronchodilate and suppress mast cell degran. Indications: cardiac arrest as a part of ALS algorithm. Anaphylaxis. Locally to vasoconstrict and reduce bleeding.
Prescription:
shockable CA- 1mg IV after 3rd shock and every 3-5 min after.
Nonshockable CA – 1mg IV asap and every 3-5min after.
Anaphylaxis – 500microgram IM, repeat after 5 min PRN.
Side effects: hypertension, anxiety, tremor, headache, palpitations, angina, MI, arrhythmia. If combined with a beta blocker may cause widespread vasocon due to unopposed alpha1 vasocon.
Admin:
CA – give whole prefilled syringe of 1:10,000 (1mg in 10ml) then flush.
Anaphylaxis – 0.5ml 1:1000 (1mg in 1ml) IM anterolateral thigh.
Amiodarone
Amiodarone
Diverse effects on myocardium. Blockade Na, Ca and K channels, anatagonise alpha and Beta adrenoceptors.
Indications: wide range of tachyarrhythmias such as A. Fib, A Flutter, SVT, VT and V Fib. Generally only used when other drugs or electrical cardioversion is inappropriate or ineffective.
Prescription: always requires senior involvement, not to be given by a FY unless for cardiac arrest
– Vfib or pulseless VT immediately after 3rd shock in ALS. 300mg IV then saline flush.
Problems – a generally messy and dangerous drug – hypotension, pneumonitis, AV block, hepatitis, thyroid problems…etc. esp when given chronically.
Angiotensin-2 receptor blockers
Angiotensin-2 receptor blockers (candesartan, irbesartan, losartan)
MOA – block action of AT2 on the AT1R. result is reduced TPR, reduced glomerular pressure, reduced aldosterone and thus preload. Indications – generally when ACEI are not tolerated. So hypertension, CHF, ischaemic CVD, diabetic nephropathy and CKD.
Prescription
– PO losartan 12.5mg OD in CHF or 50mg OD in other conditions. Then titrated up depending on response.
Problems – hypotension, hyperkalaemia, renal failure. Avoid in renal artery stenosis, AKI, pregnancy and breastfeeding. Possible angioedema but less likely than ACEI (thought to be something to do with BK metabolism.)
Aspirin
Aspirin*
Irreversible inhibitor of COX, prevents thromboxane production and thus platelet aggregation. Platelets have no nucleus so make no new COX and thus the effect lasts for the lifetime of the platelet.
Indications- treat acute ACS or ischaemic stroke. Long term prevention of thrombosis. In AF where warfarin and other oral antithrombotics cannot be used. Pain relief.
Prescription
– ACS – 300mg loading dose then 75mg OD PO.
Acute ischaemic stroke – 300mg PO OD for 2 weeks then 75mg. long term in those with risk factors that have had an acute event or have Atrial fib then 75mg PO OD, only secondary prevention as for primary prevention the risk of bleeding outweighs the benefit.
For long term treatment gastroprotection should be considered eg omeprazole 20mg OD. Take after food to minimise gastric irritation.
Problems – not given to children under 16 due to the small risk of Reye’s syndrome which is rare but life threatening and affects the liver and brain. Some people can be allergic to asthma. Avoid in third trimester of pregnancy as inhibition of prostaglandins may cause premature closure of the ductus arteriosus.
Bendroflumethiazide
Bendroflumethiazide
others = indapamide
A thiazide diuretic. Inhibits the NA/CL cotransporter in the distal convoluted tubule of the nephron. This prevents the resorption of sodium and osmotic draw of water. The resulting diuresis causes an initial fall in extracellular fluid vol but over time compensation occurs eg RAAS activation to partially reverse this. The long term antihypertensive effect is probably due to vasodilation. (some open potassium channels)
Indications: an alternative first line treatment for hypertension when CCBs are unsuitable or there are features of heart failure. Also = add on treatment for hypertension when not adequately controlled by a CCB and a ACEI or ARB.
used in chronic mild cardiac failure if renal function is normal
Prescription : bendroflumethiazide 2.5mg OD PO. There is little gained from higher doses. Best to take in the morning so the diuresis is maximal during the day rather than night so as not to disrupt sleep.
They cause a modest diuresis (5% of filtered sodium is lost in the urine). This is because the majority of sodium transport occurs earlier.
Problems – hyponatraemia due to transporter blockade (not usually a problem). Hypokalaemia due to increased delivery of Na to the distal tubule where it can be exchanged for K+, this can cause arrhythmias. Can raise plasma glucose (and thus unmask T2DM), LDL and triglycerides but are still net cardioprotective. Can cause impotence. May precipitate gout attacks due to reduced uric acid excretion.
Other – the main problem of thiazides is hypokalaemia, one of the main problems of ACEI or ARB is hyperkalaemia, thus prescribing them together causes these effects to cancel out. They also synergistically lower BP as thiazides activate the RAAS and ACEI or ARB block it.
may be ineffective in kidney failure
Calcium channel blockers
Calcium channel blockers (amlodipine, diltiazem, nifedipine, verapamil)
Reduce vascular and cardiac (Ca)i. casue vasodilation to lower ABP. Reduce myocardial contractility, suppress AVN conduction and thus slow rate. Reduce rate, contractility and afterload reduce oxygen demand and thus angina.
2 broad classes: dihydropyridines such as amlodipine and nifedipine that are relatively selective for vasculature, and non-dihydropyridines that are cardioselective, verapamil is the most cardioselective. Diltiazem is cardioselective but has some effect on vessels.
Indications: HTN – amlodipine and sometimes nifedipine are 1st or 2nd line. Stable angina – control symptoms. SVT arrhythmias – diltiazem and verapamil to control cardiac rate ie in SVT, A flutter and A fib.
Prescription: amlodipine has a long half life but the others are of only a few hours so modified release variations need to be given.
HTN – amlodipine 5-10mg PO OD.
Angina – diltiazem MR 90mg PO BDS.
SVarr – verapamil 40-120mg PO TDS.
Problems – vasodilation causes ankle swelling, flushing, headache and compensatory tachycardia causes palpitations. Verapamil commonly causes constipation. Cardiac problems can include bradycardia, heart block and cardiac failure. Non-dihydropyridine CCBs shouldn’t be given with beta blockers except under close supervision as they are both negatively inotropic and chronotropic and together can cause heart failure, bradycardia or asystole.
Clopidogrel
Clopidogrel* Irreversibly binds the ADP receptors on the surface of platelets to prevent aggregation. Independent of the COX pathway and thus act synergistically with aspirin.
Indications – generally prescribed with aspirin but can be used alone where aspirin is contraindicated.
1 -ACS.
2 - To prevent occlusion of coronary artery stents.
3 – secondary prevention of thrombotic events.
4 – in A Fib where warfarin and novel oral anticogs cant be used.
Prescribing
– loading dose of 300mg PO and maintenance dose 75mg PO OD.
Problems – bleeding and GI upset. It’s a pro-drug so has to be metabolised by CYP450 thus its effect is reduced when given with CYP450 inhibitors such as the PPI omeprazole, so give lansoprazole if worried about gastroprotection.
Digoxin
Digoxin
Negatively chronotropic and positively inotropic. In A fib and A flutter its effect is primarily via increasing vagal tone and thus is largely lost during stress and exercise and so is rarely used on its own in AF. In heart failure its effect is via inhibition of the NA/K atpase, Na accumulates and thus so does Ca.
Indications – A fib and A flut. A beta blocker or non-dihdropyridine CCB is usually more effective though.
2 - severe heart failure – third line after ACEI, beta blocker and either spironolactone or ARB.
Prescribing – loading dose of 500 micrograms, then 250-500 micrograms 6 hrs later, then maintenance on 125-250 micrograms PO OD.
Problems – therapeutic doses can cause ST depression (reverse tick sign). Loop and thiazide diuretics can increase risk of digoxin toxicity via causing hypokalaemia. Amiodarone, CCB and spironolactone can increase plasma conc of digoxin. Digoxin is proarrhythmic and has a low therapeutic index. Lots of other problems.
Dipyridamole
Dipyridamole
Antiplatelet and vasodilator. Somehow by raising cAMP. Indications – secondary prevention of stroke. First line after TIA. Second line after ischaemic stroke (clopidogrel is first line). Given with aspirin.
2 – to induce tachycardia during a myocardial perfusion scan in the diagnosis of ischaemic heart disease.
Prescription – modified release 200mg PO BDS.
Problems – side effects relate to vasodilation eg headache, flushing, dizziness. Caution in ischaemic heart disease, aortic stenosis, heart failure.
Loop diuretics
Loop diuretics (bumetanide, furosemide*)
Act principally on the ascending limb of the loop of henle inhibiting the Na/K/2Cl co transporter. Prevents water being drawn out of the loop by osmosis. Also causes dilation of capacitance veins, this is probably the root of their main benefit in acute heart failure as this effect occurs before the diuresis.
Indications -
1 – acute pulmonary oedema to reliev breathlessness with oxygen and nitrates.
2 – relieve fluid overload in chronic heart failure and other oedematous states eg renal disease or liver failure.
Prescription – IV – 40mg furosemide. Also available PO.
also used with thiazide diuretics for resistant heart failure (typically metolazone)
Problems – can be associated with basically any low electrolyte state due to how they work. Acts on a similar transporter in the inner ear that regulates endolymph so can cause tinnitus and hearing loss. Inhibit uric acid excretion and thus can worsen gout. Can affect ay drug excreted by the kidneys eg digoxin.
compared to thiazides they cause a bigger natriuresis (25% of filtered sodium can be excreted) but which lasts for a shorter duration. they are also effective at low glomerular filtration rates (as occur in chronic renal failure) where thiazide diuretics are ineffective
Nicorandil
Nicorandil
Causes venous and arterial dilation due to its actions as a nitrate and by activating K-ATP channels. Efflux of K causes hypopol and inactivation of pd gated Ca, net decrease in Cai. Effect is decreased preload, afterload and dilated coronary vessels.
Indications – stable angina – first line is beta blocker or CCB either together or alone, second line is nicorandil or long acting nitrate.
Prescription – PO only. 5-10mg BD, then 20-30mg BD due to tolerance.
Problems – due to vasodilation eg flushing, headache, also nausea, vomiting, G problems.
Nitrates
Nitrates (isosorbide mononitrate, GTN including infusions*)
Converted to NO, increases cGMP synth and reduces Cai in vascular smooth muscle. Venous capacitance vessel dilation, can dilate coronary vessels, dilate systemic arteries to reduce afterload. Most antianginal effects are through reduction of preload.
Indications – short acting agents eg GTN in angina and ACS.
2 – long acting eg isosorbide mononitrate in angina prophylaxis where a beta blocker or CCB would be insufficient.
3 – IV nitrates in treatment of pulmonary oedema, usually with furosemide and oxygen.
Prescription
– stable angina – GTN SL PRN. ACS or heart failure: GTN IV infusion continuous.
Angina prophylaxis – isosorbide mononitrate: BD/TDS or can give modified release tablets or transdermal patches OD.
Problems – vasodilation based effects eg flushing and headaches. Tolerance with sustained use. Can cause cardiovascular collapse in severe aortic stenosis. Don’t use if haemodynamically unstable. Don’t use with PDE inhibitors eg sildenafil as these enhance the hypotensive effect.
Spironolactone
Spironolactone
Aldosterone is a mineralocorticoid produced in the adrenal cortex. It acts on the distal tubules of the kidney to increase ENaC activity. This increases reabsorption of Na and whater and increases K excretion. Spironolactone competitively inhibits this.
Indications
1 – ascites and oedema due to liver cirrhosis.
2 – chronic heart failure – usually in addition to a beta blocker and an ACEI or ARB.
3 – primary hyperaldosteronism – whilst awaiting surgery.
4 - Secondary hyperaldosteronism (e.g. chronic liver disease)
Prescription - PO and OD. 100mg in ascites, 25mg in heart failure.
Problems – hyperkalaemia. Gynaecomastia. Care must be taken with other K elevating drugs such as ACEI and ARBs.
Statins
Statins
Inhibit HMG CoA reductase an enzyme involved in making cholesterol. Decrease liver production and increase LDL-cholesterol clearance from the blood. Also indirectly reduce triglycerides and slightly increase HDL-cholesterol levels. Slow or reversesthe atherosclerotic process.
Indications
– 1 – primary prevention of CV disease. Used in people over 40 with a 10 year risk of over 20percent.
2 – secondary prevention of CV disease. First line alongside lifestyle changes .
3 – primary hyperlipidaemias : first line.
Prescribing – simvastatin 40mg PO OD, or atorvastatin 10mg PO OD.
Problems – generally safe and well tolerated. Most commonly headache and GI problems. Can also cause muscle pain, myopathy or rarely rhabdomyalysis. Metabolism of statins is reduced by CYP450 inhibitors. Excreted by kidneys so reduce dose in renal disease.
Alpha-blockers
Alpha-blockers (alfuzosin, doxazocin, tamsulosin)
Most of the drugs are actually highly selective for alpha1 R eg doxazosin, tamsulosin or alfuzosin. Found mainly on smooth muscle, stim causes contraction, block relax. Blockers cause vasodilation and drop in ABP, and reduced resistance to bladder outflow.
Indication –
1 – first line to improve symptoms in benign prostatic hyperplasia.
2 – add on treatment in resistant hypertension.
Prescription
– doxazosin – 1mg OD PO to start.
Tamsulosin – prostate only, less effect on BP, 400micrograms OD PO.
Problems – due to effects on vascular tone – postural hypotension, dizziness, syncope, particularly after the first dose.
Beta-blockers
Beta-blockers (atenolol, bisoprolol, metoprolol,
Beta1 are mainly in the heart. Beta2 are mainly in the blood vessels and airways. Block of beta1 reduces force and speed of heart. Prolong refractory period of the AVN. Blockade of this receptor in the kidney reduces renin secretion.
Indications –
1 – ischaemic heart disease. First line. Angina and ACS.
2 – chronic heart failure. First line.
3 – A fib – first line to reduce rate and in paroxysmal A fib to maintain sinus rhythm.
4 – SVT – first line to restore sinus rhythm
5 – hypertension – when ACEI, thiazides and CCBs aren’t effective.
Prescription – varies by drug and indication. Start with a drug that has a short half life in acute scenarios eg ACS as this makes it more responsive to doseage changes.
Problems – fatigue, cold extremities, headache, nausea, slep disturbance, nightmares, impotence. Avoid in asthma due to bronchospasm. CANNOT use with non-dihydropyridine CCBs eg verapamil and diltiazem as this can cause heart filaure, bradycardia and asystole.
Anti-muscarinic bronchodilators
Anti-muscarinic bronchodilators (ipratropium bromide, tiotropium)
Competitive inhibitors of ACH. Reduces smooth muscle tone, reduce secretions from glands in resp and GI.
Indications –
COPD – short acting for breathlessness. Long acting to prevent exacerbations.
2 – asthma – short acting for breathlessness with beta agonists. Long acting added to high dose corticosteroids and long acting beta agonsits in step 4 of the treatment protocol.
Prescription – short acting eg ipratropium – stable patients 40micrograms QDS or PRN INH.
Acute attacks = 250-500 micrograms PRN NEBS.
2 – long acting – tiotropium – OD INH.
Problems – dry mouth but otherwise no real side effects when inhaled as lack of systemic absorption.
Inhaled steroids
Inhaled steroids (betamethasone, budesonide)
Cytoplasmic receptors, modify gene transcription. Anti-inflammatory. Reduces mucosal inflammation, widens airways, reduces mucus secretion. Improves symptoms and reduces exacerbations in asthma and COPD. Indications – 1 – asthma – step 2 where beta agonists aren’t sufficient. 2 – COPD – prescribed in combination with a long acting beta agonist and or a long acting antimuscarinic.
Prescription – beclometasone 100micrograms 2 puffs INH BD for asthma. Spacer can improve airway deposition and reduce oral side effects.
Problems – oral candidiasis, hoarse voice. Little systemic absorption except in very high doses.
Nicotine replacement therapy
Nicotine replacement therapy
Nervous system NAChR, euphoria and relaxation. Withdrawal causes craving, anxiety, depression and irritability with increased appetite. During abstinence, nicotine replacement therapy prevents withdrawal symptoms.
Varenicline is a partial agonist and reduces withdrawal sympt and the rewarding effects of tobacco nicotine via competition.
Bupropion increases conc of noradrenaline and dopamine via inhibiting reuptake. MOA not fully understood.
Indications – smoking cessation – used alongside non-pharmacological measures to address the psychological and behavioural aspects of dependence.
Prescription – continuous release patch to reduce or prevent craving and/or immediate release preparation such as SL tablets, sprays and gum to control the acute urge. Treatment should start before a cessation attempt to reduce the number smoked per day. If smoking over 10 per day start with high dose patch for 6-8 weeks, then wean to medium/low dose for 2 weeks before stopping.
Varenicline or bupropion should start 1 – 2 weeks before the target quit date. Low starting dos etitrated over first week to optimal treatment doe then continued for 9-12 weeks.
Problems – local irritation. GI upset with oral nicotine. Palpitations, abnormal dreams.
Varenicline – nausea, headache, insomnia, rarely – suicidal ideation.
Bupropion – dry mouth, GI upset, headache, insomnia, depression.
Can precipitate siezures in thoe susceptible. Care in psychiatric disease.
Bupropion – metabolised by CYP450 so careful with other interacting drugs.
Cost - £150 for 12 weeks so pt must have a clear idea of how and when they will quit beforehand.
Beta-agonists
Beta-agonists (e.g.salbutamol*) Beta2 R found in the smooth muscle of bronchi, GI tract, uterus and blood vessels. Stimulation causes relaxation. Also stimulates NaK ATPase to shift K from the extracellular to the intraceluar compartment so useful in hyperkalaemia.
Prescription – short acting PRN. Common in adults in 100-200micrograns INH. Long acting – used in a combi inhaler with cortico to ensure use.
Metered dose inhaler = aerosol. Other option is ry powder. A spacer can help with airway deposition.
Indications
- 1- asthma – short acting to relieve breathlessness. Long acting in step 3 for chronic asthma but ALWAYS to be used in combination with corticosteroids.
2 – COPD – short acting to relieve breathlessness. Long acting are an option for second line maintenance.
3 – hyperkalaemia – nebulised salbutamol can be given alongside insulin, glucose and calcium gluconate for the urgent treatment of high serum K+.Problems – due to action in other tissues – tachycardia, palpitations, anxiety or tremor. Promotes glycogenolysis so may increase serum glucose. Long acting agonsits can cause muscle cramps.
Be careful when prescribing to patients with concurrent cardiovascular disease.
Long acting agonists are only used in asthma when with a corticosteroid as without it they are associated with increased asthma deaths.
Costs – combi inhalers are expensive – seretide and one other combi inhaler together account for £500million per annum.
Atypical antipsychotics
Atypical antipsychotics (quetiapine, olanzapine)
Block post synaptic D2R. there are 3 main DA pathways in the brain that these then target = mesolimbic/mesocortical pathway between the midbrain and the limbic system/frontal cortex. 2 – nigrostriatal from the substancia nigra to the corpus striatum of the basal ganglia. 3 – tuberohypophyseal pathway between the hypothalamus and the pituitary. The main effect of the atypical antipsychotics is believed to be via the mesocoticolimbic pathway.
Features that distinguish second gen from first gen (the ‘typical antipsychotics) are improved efficacy in ‘treatment resistant’ schizophrenia (particularly clozapine) and against some negative symptoms, and a lower risk of extrapyramidal symptoms. Possibly due to a higher affinity for other receptors esp 5HT and looser binding to D2.
Indications
– 1 – urgent treatment of severe psychomotor agitation leading to dangerous or violent behaviour, or to calm such patients to permit assessment.
2 – schizophrenia – particularly when extrapyramidal side effects have complicated the use of typial (first gen) antipsychotics, or when negative symptoms are prominent.
3 – bipolar disorder – particularly in acute episodes of mania or hypomania.
Prescription – specialist only. Most likely to encounter when the pt is already on them – shouldn’t stop but should check if current presentation could be caused by them or an interaction with the current disease or other drugs being given.
Problems – always check the QT interval as most antipsychotics can lengthen this to sme extent which presents a risk of arrhythmias which may be exacerbated by medications you give eg macrolide antibiotics. Other – sedation. Extrapyramidal effects (movement abnormalities due to blockade of nigrostriatal pathway. Metabolic disturbance such as weight gain, diabetes and lipid changes are a common problem. QT prolongation.
Benzodiazepines
Benzodiazepines (chlordiazepoxide, diazepam, lorazepam, midazolam, temazepam)
Target is the GABAa R. this is a Cl channel. Benzos facilitate and enhance binding of GABA to the R and thus decrease neuron excitability. Result is reduced anxiety, sleepiness, sedation and anticonvulsion. Ethanol acts in a similar manner, thus sudden ethanol removal of ethanol causes withdrawal that can be treated with a benzo that can have its dose titred down to reduce withdrawal symptoms.
Indications
– 1 – first line in siezures and status epilepticus.
2 – first line in alcohol withdrawal
3 – common choice for sedation is general anaesthesia is unnessecary or unavailable.
4 – for short term treatment of severe, diasbly or distressing anxiety.
5 – short term treatment of severe, disabling or distressing insomnia.
Prescribing – the effects of the various benzos are similar, the differences are the length of effects.
- Siezures – long acting – lorazepam 4mg IV or diazepam 10mg IV.
- Alcohol withdrawal – oral chlordiazepoxide
- Sedation – short acting to allow raid recovery eg midazolam. Problems – dose dependent drowsiness, sedation and coma. Dependence can develop, abrupt cessation then causing withdrawal. The elderly are more susceptible. Avoid in resp impairment or neuromuscular disease. Most depend on CYP450 for elimination.
Co-codamol, co-dydramol
Co-codamol, co-dydramol
Compound preparations of paracetamol and weak opioids codeine and dihydrocodeine.
Indications – the second rung on the WHO pain ladder. Used when NSAIDS are insufficient.
Prescriptions – all tablets contain 500mg of paracetamol but the dose of opioid varies eg 8/500 or 10/500. If paracetamol has failed consider co-codamol 15/500 2 tabs 6hrly. Only available as PO. Should take doses at regular intervals.
Problems – same as opioid – nausea, constipation, drowsiness, hepatotoxicity etc. take care with hepatic/renal impairment and elderly.